<DOC>
	<DOCNO>NCT00899665</DOCNO>
	<brief_summary>RATIONALE : Collecting store sample bone marrow tissue patient test laboratory may help study cancer . PURPOSE : This laboratory study compare protease ( enzymes break protein ) patient prostate cancer spread bone patient cancer spread bone .</brief_summary>
	<brief_title>Proteases Patients With Prostate Cancer That Has Spread Bone</brief_title>
	<detailed_description>OBJECTIVES : - Examine roles proteases protease-associated molecule bone metastases patient metastatic prostate cancer . OUTLINE : Patients undergo bone marrow aspiration core bone biopsy . Tissues analyze immunohistochemistry method , situ hybridization assay , gelatin zymography and/or Western blot analysis , gene profile analysis order visualize quantitate protease protease-related level . PROJECTED ACCRUAL : A total 50 patient accrue study .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Meets 1 follow criterion : Diagnosis metastatic prostate cancer Patients document bone metastasis radiologic image study must undergo bone marrow biopsy Male patient ≥ 50 year age without cancer schedule undergo bone biopsy clinically indicated reason , include follow : Myelodysplasia Anemia Monoclonal gammopathy undetermined significance Male female patient ≥ 40 year age without metastatic bone cancer schedule undergo orthopedic procedure involve removal bone specimen PATIENT CHARACTERISTICS : See Disease Characteristics PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>stage IV prostate cancer</keyword>
	<keyword>bone metastasis</keyword>
	<keyword>anemia</keyword>
	<keyword>monoclonal gammopathy undetermined significance</keyword>
	<keyword>de novo myelodysplastic syndrome</keyword>
	<keyword>previously treat myelodysplastic syndrome</keyword>
	<keyword>secondary myelodysplastic syndrome</keyword>
</DOC>